Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...

A NEW weight loss jab that only needs to be taken once monthly leads to “substantial weight loss”, according to early trials. Drugs like Wegovy and Mounjaro – or diabetes jab Ozem… ...

A drug that can be taken orally could soon rival the likes of Ozempic for treating type 2 diabetes and obesity, according to a new study. Although its efficacy hasn't yet been tested in humans ...

There’s no such thing as "natural Ozempic." While supplements like psyllium, berberine, and glucomannan are paraded as plant-powered weight-loss miracles, their effects don’t even come close to ...

Demand for glucagon-like peptide-1 weight-loss drugs — such as Ozempic, Zepbound and Wegovy — coupled with limited insurance coverage has fueled a risky but growing “gray” market for purchasing active ...

How to buy Ozempic stock While you can't directly buy stock in Ozempic itself, you can invest in Novo Nordisk, the pharmaceutical company that manufactures Ozempic and Wegovy.

Dr. Mahsa Tehrani discusses how patients use medication to help them lose weight on 'America Reports.' ...

He’s also very sensitive about his weight. Is it wrong for me to try to get him to take Ozempic? I’m hoping that losing weight will help boost his energy levels, which might lead to more self ...

A new oral drug may be able to treat type 2 diabetes and obesity without impacting muscle mass as an alternative to GLP-1 drugs such as Ozempic, the results of a phase 1 clinical trial suggest.

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also cause pregnancy complications and harm some users.

Ozempic and similar GLP-1 drugs seem to be hurting some people’s pancreas. UK health officials are planning to study the link between GLP-1 use and acute pancreatitis, following an increase in ...